Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System
NCT00706095
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
E7389
DRUG:
E7389
DRUG:
E7389
Sponsor
Eisai Inc.